Successful treatment of refractory adult onset Still's disease with rituximab

• Asıl Yazarlar: N. Belfeki (Yazar), M. Smiti Khanfir (Yazar), F. Said (Yazar), A. Hamzaoui (Yazar), T. Ben Salem (Yazar), I. Ben Ghorbel (Yazar), M. Lamloum (Yazar), M.H. Houman (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: PAGEPress Publications, 2016-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Adult-onset Still's disease (AOSD) is an uncommon inflammatory condition of unknown origin. In chronic disease, joint involvement is often predominant and erosions are noted in one third of patients. Therapeutic strategies derive from observational data. Corticosteroids are usually the first-li...